Literature DB >> 33250305

Effect of complexing lipids on cellular uptake and expression of messenger RNA in human skin explants.

Anna K Blakney1, Polina Deletic2, Paul F McKay2, Clément R Bouton2, Marianne Ashford3, Robin J Shattock2, Alan Sabirsh4.   

Abstract

Messenger RNA (mRNA) represents a promising next-generation approach for both treatment and vaccination. Lipid based particles are one of the most investigated delivery systems for mRNA formulations. Here we explore how the complexing lipid affects uptake and translation of lipoplex-delivered RNA in resident cells in human skin explants and, we explore a more modular delivery system that utilizes mRNA added to pre-formed nanoparticles prior to dosing. We prepared formulations of lipoplexes with ionizable, cationic or zwitterionic lipids, externally complexed these with mRNA, and observed which cells internalized and/or expressed the mRNA over 72 h after intradermal injections into primary, human, skin explants. Using a flow cytometry panel to assess cellular phenotypes, mRNA uptake and mRNA expression, we found that, unlike other cell types, adipocytes expressed mRNA efficiently at 4 and 24 h after mRNA-lipoplex injection and contributed the greatest proportion of total RNA-encoded protein expression, despite being the lowest frequency cell type. Other cell types (epithelial cells, fibroblasts, T cells, B cells, dendritic cells, monocytes, NK cells, Langerhans cells, and leukocytes) had increasing mRNA expression over the course of 72 h, irrespective of lipoplex formulation. We observed that overall charge of the particle, but not the complexing lipid classification, was predictive for the pattern of mRNA uptake and expression among resident cell types in this model. This study provides insight into maximizing protein expression, using modular mRNA lipoplexes that are more compatible with product development, in a clinically relevant, human skin explant model. Crown
Copyright © 2020. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipocytes; Human skin; Lipid nanoparticles; Messenger RNA; Nucleic acid

Mesh:

Substances:

Year:  2020        PMID: 33250305     DOI: 10.1016/j.jconrel.2020.11.033

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach.

Authors:  Han Han Ly; Simon Daniel; Shekinah K V Soriano; Zoltán Kis; Anna K Blakney
Journal:  Mol Pharm       Date:  2022-05-23       Impact factor: 5.364

Review 2.  mRNA Vaccines: Why Is the Biology of Retroposition Ignored?

Authors:  Tomislav Domazet-Lošo
Journal:  Genes (Basel)       Date:  2022-04-20       Impact factor: 4.141

Review 3.  Strategies to deliver RNA by nanoparticles for therapeutic potential.

Authors:  Alysia Cox; Siyoung A Lim; Eun Ji Chung
Journal:  Mol Aspects Med       Date:  2021-08-05

4.  Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein.

Authors:  Nigel Davies; Daniel Hovdal; Nicholas Edmunds; Peter Nordberg; Anders Dahlén; Aleksandra Dabkowska; Marianna Yanez Arteta; Aurel Radulescu; Tomas Kjellman; Andreas Höijer; Frank Seeliger; Elin Holmedal; Elisabeth Andihn; Nils Bergenhem; Ann-Sofie Sandinge; Camilla Johansson; Leif Hultin; Marie Johansson; Johnny Lindqvist; Liselotte Björsson; Yujia Jing; Stefano Bartesaghi; Lennart Lindfors; Shalini Andersson
Journal:  Mol Ther Nucleic Acids       Date:  2021-03-13       Impact factor: 8.886

5.  Learning to see colours: Biologically relevant virtual staining for adipocyte cell images.

Authors:  Håkan Wieslander; Ankit Gupta; Ebba Bergman; Erik Hallström; Philip John Harrison
Journal:  PLoS One       Date:  2021-10-15       Impact factor: 3.240

6.  Liposomes as Adjuvants and Vaccine Delivery Systems.

Authors:  D S Tretiakova; E L Vodovozova
Journal:  Biochem (Mosc) Suppl Ser A Membr Cell Biol       Date:  2022-02-14

Review 7.  The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA.

Authors:  Laura Taina-González; María de la Fuente
Journal:  Pharmaceutics       Date:  2022-02-21       Impact factor: 6.321

Review 8.  A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA.

Authors:  Ioana Toma; Alina Silvia Porfire; Lucia Ruxandra Tefas; Ioana Berindan-Neagoe; Ioan Tomuță
Journal:  Pharmaceutics       Date:  2022-07-16       Impact factor: 6.525

Review 9.  Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy.

Authors:  Yusi Wang; Rui Zhang; Lin Tang; Li Yang
Journal:  Pharmaceutics       Date:  2022-02-25       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.